Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Non-randomized Multicenter Study to Assess the Efficacy Response Duration and Toxicity of RFC as First-line Treatment and R as Maintenance Treatment, in Patients Diagnosed of Follicular Non Hodgkin Lymphoma

NCT01124526 is registered in ClinicalTrials.gov with Asociacion Espanola de Hematologia y Hemoterapia as lead sponsor.

NCT NCT01124526
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01124526 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Non-randomized Multicenter Study to Assess the Efficacy Response Duration and Toxicity of RFC as First-line Treatment and R as Maintenance Treatment, in Patients Diagnosed of Follicular Non Hodgkin Lymphoma
Lead sponsor
Asociacion Espanola de Hematologia y Hemoterapia
Phase
Phase 4
Overall status
Completed
Start date
September 30, 2004
Completion date
July 31, 2008
Enrollment
75 (actual)
Sites
20

Conditions

As the registry lists them; a condition with its own page is linked.

non hodgkin lymphoma